| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6156871 | American Journal of Kidney Diseases | 2015 | 8 Pages |
Abstract
A >30% decline in kidney function assessed using novel filtration markers is associated strongly with ESRD, suggesting the potential utility of measuring change in cystatin C and B2M levels in settings in which improved outcome ascertainment is needed, such as clinical trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Casey M. PhD, MS, MPH, Morgan E. MD, PhD, MHS, Kunihiro MD, PhD, Elizabeth PhD, MPH, Josef MD, PhD, MHS,